Press Releases April 27, 2026 09:00 AM

The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call

The Oncology Institute schedules Q1 2026 earnings release and conference call

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
TOI

The Oncology Institute, Inc., listed on NASDAQ as TOI, announced that it will release its first quarter 2026 financial results on May 7, 2026, with a conference call held the same day to discuss results. The company continues to advance value-based community oncology care across five states with over 100 clinic locations.

The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call
TOI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • TOI will report its Q1 2026 earnings on May 7, 2026, followed by a conference call for investors.
  • The Oncology Institute operates over 100 clinics and affiliate locations across five states, serving about 1.9 million patients.
  • The company focuses on advancing value-based, evidence-based oncology care including clinical trials and transfusions in the community setting.

CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).

The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 11161701. The replay will be available until Thursday May 21, 2026.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.

About The Oncology Institute

Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.

Contacts

Media

The Oncology Institute, Inc.
marketing@theoncologyinstitute.com

Investors

ICR Healthcare
TOI@icrhealthcare.com


Risks

  • Financial performance for Q1 2026 may vary and impact investor sentiment upon release.
  • Growth and expansion efforts across multiple states may face regulatory, operational, or competitive challenges.
  • Healthcare market dynamics such as reimbursement policies and pandemic impacts may affect oncology care providers like TOI.

More from Press Releases

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026